Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT02473874
Other study ID # 20151791
Secondary ID
Status Withdrawn
Phase
First received
Last updated
Start date June 2015
Est. completion date January 2020

Study information

Verified date October 2022
Source University of California, Irvine
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to obtain skin spectroscopic data from two imaging systems. Comparison groups: - Skin Spect dermoscope - Spatially modulated quantitative spectrometer


Description:

The researcher can compare the spectroscopic data from the two systems as well as the relative concentrations of melanin, oxy- and deoxy- hemoglobin calculated from the measurements. Skin Spect can measure larger area of skin, whereas Spatially modulated quantitative spectrometer is a point-based measurement.Therefore, larger nevi will require multiple Spatially modulated quantitative spectrometer measurements for comparison with corresponding sub-regions of the larger Skin Spect measurements. Only sub-regions of the image data from Skin Spect that match the locations Spatially modulated quantitative spectrometer acquired data will be used in this correlation study. This researcher ensure that the spectral data collected by the two instruments are collected from the same spatial locations, should lesion heterogeneity be present.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date January 2020
Est. primary completion date January 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - Skin lesion a mole located on flat surface of the body Exclusion Criteria: - Mole located on complex surface - Pregnant women

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Skin Spect dermoscope
Skin imaging
Spatially modulated quantitative
Skin imaging

Locations

Country Name City State
United States Beckman Laser Institute Irvine California

Sponsors (2)

Lead Sponsor Collaborator
University of California, Irvine Beckman Laser Institute University of California Irvine

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in human skin structure Comparison Imaging Changes in human skin structure Between Spatially Modulated Quantitative Spectroscopy and Skin Spect Dermoscopy up to 12 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT03699995 - MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma N/A